These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1294672)

  • 21. Effect of Bacteroides fragilis cellular components on chemotactic activity of polymorphonuclear leukocytes towards Escherichia coli.
    Namavar F; Verweij-Van Vught AM; Bal M; MacLaren DM
    J Med Microbiol; 1987 Sep; 24(2):119-24. PubMed ID: 3309320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenic synergy between Escherichia coli and Bacteroides fragilis or B. vulgatus in experimental infections: a non-specific phenomenon.
    Verweij-van Vught AM; Namavar F; Vel WA; Sparrius M; MacLaren DM
    J Med Microbiol; 1986 Feb; 21(1):43-7. PubMed ID: 3512833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of capsular polysaccharide and lipopolysaccharide of Bacteroides fragilis on polymorph function and serum killing.
    Connolly JC; McLean C; Tabaqchali S
    J Med Microbiol; 1984 Jun; 17(3):259-71. PubMed ID: 6374150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phagocytic and serum killing of capsulate and non-capsulate Bacteroides fragilis.
    Reid JH; Patrick S
    J Med Microbiol; 1984 Jun; 17(3):247-57. PubMed ID: 6726784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of prophylactic antibiotics upon mixed infections with Bacteroides fragilis.
    Brook I
    Surg Gynecol Obstet; 1987 Dec; 165(6):491-5. PubMed ID: 3317944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anaerobic infection of the liver and biliary tract in experimental common duct occlusion.
    Justesen T; Nielsen ML
    Scand J Infect Dis Suppl; 1979; (19):35-41. PubMed ID: 379988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Escherichia coli hemoglobin protease autotransporter contributes to synergistic abscess formation and heme-dependent growth of Bacteroides fragilis.
    Otto BR; van Dooren SJ; Dozois CM; Luirink J; Oudega B
    Infect Immun; 2002 Jan; 70(1):5-10. PubMed ID: 11748157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of encapsulated Bacteroides asaccharolyticus and Bacteroides fragilis on the growth of aerobic and facultative bacteria in mixed infections.
    Brook I
    J Surg Res; 1989 Jul; 47(1):92-5. PubMed ID: 2739405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin.
    Sofianou D; Douboyas J; Papapanagiotou J; Paradelis AG
    Methods Find Exp Clin Pharmacol; 1982; 4(3):173-7. PubMed ID: 7121128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic efficacy of moxifloxacin, a new quinolone, in the treatment of experimental intra-abdominal abscesses induced by Bacteroides fragilis in mice.
    Thadepalli H; Chuah SK; Gollapudi S
    Chemotherapy; 2004 Jun; 50(2):76-80. PubMed ID: 15211081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentiation of phagocytosis of Bacteroides fragilis following incubation with clindamycin.
    Howard RJ; Soucy DM
    J Antimicrob Chemother; 1983 Oct; 12 Suppl C():63-8. PubMed ID: 6643342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Bacteroides fragilis on mortality induced by Escherichia coli in an experimental infection treated with cefotaxime, aztreonam or gentamicin.
    Soriano F; Ponte C; Santamaría M; Castilla C
    J Antimicrob Chemother; 1989 Mar; 23(3):383-8. PubMed ID: 2659565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of macrophage procoagulant activity by Bacteroides fragilis.
    Rosenthal GA; Levy G; Rotstein OD
    Infect Immun; 1989 Feb; 57(2):338-43. PubMed ID: 2643564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The quantitative and histological demonstration of pathogenic synergy between Escherichia coli and Bacteroides fragilis in guinea-pig wounds.
    Kelly MJ
    J Med Microbiol; 1978 Nov; 11(4):513-23. PubMed ID: 364068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conjugal transfer of antibiotic resistance factors in Bacteroides fragilis: the btgA and btgB genes of plasmid pBFTM10 are required for its transfer from Bacteroides fragilis and for its mobilization by IncP beta plasmid R751 in Escherichia coli.
    Hecht DW; Jagielo TJ; Malamy MH
    J Bacteriol; 1991 Dec; 173(23):7471-80. PubMed ID: 1657890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrin in peritonitis. IV. Synergistic intraperitoneal infection caused by Escherichia coli and Bacteroides fragilis within fibrin clots.
    Dunn DL; Rotstein OD; Simmons RL
    Arch Surg; 1984 Feb; 119(2):139-44. PubMed ID: 6365029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clindamycin resistance in anaerobic bacteria.
    Tally FP; Cuchural GJ; Bieluch VM; Jacobus NV; Malamy MH
    Scand J Infect Dis Suppl; 1984; 43():34-43. PubMed ID: 6598519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of macrophage phagocytosis by Bacteroides fragilis in vivo and in vitro.
    Rodloff AC; Becker J; Blanchard DK; Klein TW; Hahn H; Friedman H
    Infect Immun; 1986 May; 52(2):488-92. PubMed ID: 3699894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice.
    Brook I
    J Infect Dis; 1989 Oct; 160(4):651-6. PubMed ID: 2677161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The treatment of irradiated mice with polymicrobial infection caused by Bacteroides fragilis and Escherichia coli.
    Brook I; Ledney GD
    J Antimicrob Chemother; 1994 Feb; 33(2):243-52. PubMed ID: 8182005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.